8-K 1 final8kldmicro2019.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): December 9, 2019
AMERICAN SHARED HOSPITAL SERVICES
(Exact name of registrant as specified in charter)
California | 1-08789 | 94-2918118
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.)
Two Embarcadero Center, Suite 410, San Francisco, CA 94111
(Address of principal executive offices)
Registrant’s telephone number, including area code 415-788-5300
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
American Shared Hospital Services Common Stock, No Par Value |  | AMS |  | NYSE AMERICAN

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01 Regulation FD Disclosure.
American Shared Hospital Services (the “Company”) has announced that Chairman and Chief Executive Officer Ernest A. Bates, M.D., Chief Operating and Financial Officer Craig K. Tagawa, and Vice President of Sales and Business Development Ernest R. Bates will present at the 12 th Annual LD Micro Main Event 2019 Conference on December 10, 2019. The Company intends to use the presentation furnished as Exhibit 99.1 to this Form 8-K at the conference. The slides from the presentation are attached hereto as Exhibit 99.1 and are hereby incorporated by reference.
Certain Information
The information in this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to this Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit 99.1 Presentation material from the 12th Annual LD Micro Main Event 2019 Conference, dated December 10, 2019

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|  | American Shared Hospital Services
Date: | December 9, 2019 |  | By: | /s/ Ernest A. Bates, M.D.
|  |  |  | Name: | Ernest A. Bates, M.D.
|  |  |  | Title: | Chairman and Chief Executive Officer